本文章的学术内容和语言评估
本文章的CrossCheck查重和Google搜索
本文章的学术规范
本文章的引用
本文章的通讯作者
本文章的研究领域
本文章的类型
本文章的开放获取政策
本文章的Google引用次数
本文章的点击和下载次数
- 本文章浏览次数 (3045)
All Articles published online
|
Publishing Process of This Article
|
Feb 27, 2024 (publication date) through Dec 18, 2024
本文章的被引频次
本文章的期刊信息
出版物名称
World Journal of Hepatology
ISSN
1948-5182
本文章的出版商
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yang M, Zhang CY. Interleukins in liver disease treatment. World J Hepatol 2024; 16(2): 140-145 [PMID: 38495285 DOI: 10.4254/wjh.v16.i2.140] |
|---|---|
| URL: | https://www.wjgnet.com/1009-3079/full/v16/i2/140.htm |
| 编号 | Citing Articles |
| 1 |
Marzia Tagliaferro, Mariapaola Marino, Valerio Basile, Krizia Pocino, Gian Ludovico Rapaccini, Gabriele Ciasca, Umberto Basile, Valeria Carnazzo. New Biomarkers in Liver Fibrosis: A Pass through the Quicksand?. Journal of Personalized Medicine 2024; 14(8): 798 doi: 10.3390/jpm14080798
|
| 2 |
Shulin Fu, Jingyang Li, Jiarui You, Siyu Liu, Qiaoli Dong, Yunjian Fu, Ronghui Luo, Yamin Sun, Xinyue Tian, Wei Liu, Jingyi Zhang, Yu Ding, Yitian Zhang, Wutao Wang, Ling Guo, Yinsheng Qiu. Baicalin attenuates PD-1/PD-L1 axis-induced immunosuppression in piglets challenged with Glaesserella parasuis by inhibiting the PI3K/Akt/mTOR and RAS/MEK/ERK signalling pathways. Veterinary Research 2024; 55(1) doi: 10.1186/s13567-024-01355-1
|
| 3 |
Nouhoum Bouare, Jean Delwaide. Interleukin-mediated therapies in liver diseases and comorbidity effects. World Journal of Hepatology 2024; 16(7): 980-989 doi: 10.4254/wjh.v16.i7.980
|
| 4 |
Anil Khushalrao Shendge, Israel Sekler, Michal Hershfinkel. ZnR/GPR39 regulates hepatic insulin signaling, tunes liver bioenergetics and ROS production, and mitigates liver fibrosis and injury. Redox Biology 2024; 78: 103403 doi: 10.1016/j.redox.2024.103403
|